- Home
- A-Z Publications
- Current Drug Safety
- Fast Track Listing
Current Drug Safety - Online First
Description text for Online First listing goes here...
31
results
1 - 20 of 31 results
-
-
Optimizing Antibiotic Use and Awareness in Hospitals: Establishing Effective Antimicrobial Stewardship Pathways
Authors: Bianca Maria Donida, Grazia Mingolla and Antonio ManfrediAvailable online: 09 May 2025More LessIntorduction Antibiotic resistance poses a significant challenge in healthcare, requiring effective management of antibiotic use. This study examines systemic antibiotic consumption at ASST Bergamo Ovest, a northern Italian hospital, from January 2022 to June 2023, with a focus on Healthcare-Associated Infections (HAIs) and prescription appropriateness. This retrospective observational study aims to analyze antibiotic usage tr Read More
-
-
-
Risk Assessment of Amiodarone Use in Patients with Cirrhosis and Heart Failure
Authors: Kazuhiko Kido and Mohammad A. Al-MamunAvailable online: 08 May 2025More LessIntroduction Limited clinical evidence exists regarding the safety profile of amiodarone therapy in patients with heart failure (HF) who already have underlying cirrhosis. The present study aimed to investigate the safety profile of amiodarone in patients with cirrhosis and HF concomitantly. Methods This was a retrospective cohort study with the TriNetX database using ICD-10 codes. Patients aged > 18 years with HF and cirrh Read More
-
-
-
A Descriptive Analysis from VigiAccess on Drug-related ProblemsAssociated with the Glucagon-like Peptide-1 Receptor Agonists
Available online: 07 May 2025More LessIntroduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely accepted for managing Type 2 Diabetes Mellitus. However, numerous drug-related problems (DRPs) have recently been reported about GLP-1 RAs. The present descriptive study aims to compile and report the DRPs of various GLP-1 RAs. Methods The DRPs reported for all the GLP-1 RAs, including exenatide, lixisenatide, liraglutide, dulaglutide, semagluti Read More
-
-
-
Understanding and Mitigating Cardiotoxicity in Anticancer Drug Therapy: A Comprehensive Review
Authors: Siwani Devi, Sarita Sharma, Deepa Rani, Karan Goel, Sweta Singh and Kishan TripathiAvailable online: 06 May 2025More LessCancer and heart disease stand as the leading global causes of morbidity and mortality. Although advancements in cancer treatment have improved survival rates, the associated cardiovascular risks cannot be overlooked. This paper delves into the intricate relationship between cancer treatment and adverse cardiovascular events, emphasizing the critical role of factors such as drug type, dosage, administration mode, a Read More
-
-
-
A Rare Case of Peripheral Edema Induced by Topical Minoxidil: A Case Report
Authors: Hassan Alkhwildi, Sara Alsaffar and Carina BethlehemAvailable online: 06 May 2025More LessIntroduction Minoxidil, initially developed as an oral antihypertensive, is widely used topically for hair regrowth. Off-label applications, such as beard enhancement, have gained popularity. While generally safe, systemic absorption of topical minoxidil can lead to rare side effects, like peripheral edema. Case Presentation A 17-year-old male developed peripheral edema seven weeks after starting topical minoxidil 5% to promote Read More
-
-
-
Adverse Drug Reactions of Low and Standard Doses of Risperidone in Schizophrenia Outpatients
Available online: 18 April 2025More LessIntroduction Risperidone is an atypical antipsychotic commonly used in the treatment of schizophrenia. Despite its effectiveness, several adverse drug reactions can be bothersome to patients. This study aimed to examine the prevalence and characteristics of adverse effects in outpatients with schizophrenia treated with low (<4 mg/day) and standard (≥4 mg/day) doses of risperidone. Methods A cross-sectional study was c Read More
-
-
-
Tubulointerstitial Nephritis in ANCA-Associated Vasculitis as a Rare Adverse Effect of Adalimumab: A Case Report
Authors: Myriam Ayari, Maha Mtir, Ikram Mami, Lamia Rais, Sarah Ben Azouz, Hedi Douggui and Taieb JomniAvailable online: 26 March 2025More LessBackground Patients with inflammatory disease treated with biological agents are at an increased risk of developing various adverse effects. However, little is known about the risk of nephrotoxicity, such as induced tubulointerstitial nephritis and immune-mediated inflammatory diseases involving the interstitium and renal tubule. Case Presentation We herein describe a case of biopsy-proven tubulointerstitial nephritis, ind Read More
-
-
-
Linezolid Related Adverse Effects in Different Populations: A Practical Review
Available online: 25 March 2025More LessLinezolid, an oxazolidinone antibiotic, is used to treat gram-positive infections. Linezolid, an oxazolidinone antibiotic, is used to treat gram-positive infections. However, it may also lead to serious adverse effects, including bone marrow suppression, optic neuropathy it may also lead to serious adverse effects, including bone marrow suppression, optic neuropathy, peripheral neuropathy, hyponatremia, and lactic acidosis. This re Read More
-
-
-
Clinical Manifestations of Neuropathic Pain and the Deleterious Effects of Chemotherapeutic Agents
Authors: Moumita Ghosh, Manodeep Chakraborty, Ananya Bhattacharjee and Nihar Ranjan BhuyanAvailable online: 24 March 2025More LessNeuropathic pain is a type of pain resulting from damage or dysfunction of the nervous system. Chemotherapy-induced peripheral neurotoxicity (CIPN) is a serious complication of cancer treatment, often occurring in a dose-dependent manner. CIPN is a sensory neuropathic syndrome characterized by motor and autonomic alterations of varying intensity and duration. The lack of effective treatment options for CIPN ma Read More
-
-
-
Self-Micro-Emulsifying Drug Delivery Systems: In-Depth Review on Enhancing Solubility and Therapeutic Efficacy of BCS Class II Drugs
Authors: Lipanjali Badhei, Prafulla Nandi, Debashis Mishra and Himansu Bhusan SamalAvailable online: 13 March 2025More LessThe development of self-micro-emulsifying drug delivery system (SMEDDS) has revolutionized pharmaceutical formulation by providing an advanced method of increasing medication bioavailability and therapeutic effectiveness. The systems encapsulate hydrophobic drugs in nanoscale droplets and enable them to be soluble and stable in water via the spontaneous formation of oil in water emulsions when gently agitated Read More
-
-
-
Certolizumab-Induced Urticarial Vasculitis: A Case Report
Available online: 13 March 2025More LessIntroduction Certolizumab (CZ) is a tumour necrosis factor-α (TNF-α) blocking agent with excellent efficiency in rheumatoid arthritis (RA). Urticarial vasculitis (UV) induced by CZ is a rare side effect. Herein, we describe a patient with UV probably induced by CZ therapy. Case Presentation A 33-year-old female with RA was treated with methotrexate and corticosteroids, which resulted in no improvement. The patient was switche Read More
-
-
-
Revealing the Future of Pharmacovigilance in Precision Pharmaceutical Monitoring
Authors: Vishnu Mittal and Anjali SharmaAvailable online: 11 March 2025More LessThe growing popularity of personalized medicine presents new hazards and difficulties for pharmacovigilance. This implies that it needs to modify its current approach. This research examines how drug safety monitoring for certain medications evolves over time. We briefly discuss the connection between meticulous pharmacovigilance procedures and adaptable treatment approaches. We describe how pharmacogenet Read More
-
-
-
Managing Opioid Tolerance: Balancing Pain Relief and Tackling Addiction
Authors: Astha Mehta, Anunav Ashish and Shubham ThakurAvailable online: 10 March 2025More LessThis editorial discusses opioid tolerance, a growing challenge in managing pain in chronic patients. With time, overuse of opioids causes less sensitivity and responsiveness of opioid receptors and leads to higher doses of opioids for the same level of pain management. Due to this, it increases the risk of side effects, such as opioid addiction, respiratory issues, and overdose. The editorial highlights the relationship betw Read More
-
-
-
Efficacy and Safety Profile of Suvorexant for the Treatment of Insomnia
Authors: Ariba Sabat, Aakriti Garg and Mohd Ashif KhanAvailable online: 03 March 2025More LessInsomnia is becoming a concern in general practice as it affects around 30% of adults. It is a sleep disorder characterized by trouble getting asleep, staying asleep, waking up early, and difficulty falling back to sleep. The most commonly used hypnotics, such as benzodiazepines, Z drugs, etc, are associated with various issues, including psychomotor and cognitive impairment. Dual orexin receptor antagonists are an emerging clas Read More
-
-
-
A Biochemical Investigation of the Prevalence of Hypercalcemia and Thiazide-Related Hypercalcemia in Patients
Available online: 25 February 2025More LessIntroduction and ObjectiveHypercalcemia allied with thiazide diuretics is a widely acknowledged clinical presentation. Hence, the purpose of this investigation was to ascertain the prevalence of hypercalcemia and hypercalcemia linked to thiazides and to evaluate serum phosphorous, 25-hydroxyvitamin D, and parathyroid hormone (PTH).MethodsThis prospective, cross-sectional research study involved all patients, includi Read More
-
-
-
Opioid Use Disorders: Prevention, Diagnosis, and Treatment Strategies to Mitigate Addiction Risks
Authors: Uma Agarwal, Khushboo Singhal and Rajiv Kumar TonkAvailable online: 20 February 2025More LessOpioid Use Disorder (OUD) is defined by the persistent use of opioids despite adverse consequences. It is associated with increased mortality and a variety of mental and general medical comorbidities. Risk factors include younger age, male sex, lower educational attainment, lower income, and psychiatric disorders, such as other substance use disorders and mood disorders. Genetics also play a role in susceptibility to opioid use Read More
-
-
-
Transdermal Drug Delivery Systems: Integrating Modern Technology for Enhanced Therapeutics
Available online: 11 February 2025More LessIntroduction/Objective In recent years, transdermal drug delivery systems (TDDS) have gained popularity as a non-invasive, patient-friendly medication delivery method. This review article examines the latest transdermal medication delivery developments and breakthroughs. The review begins with a brief summary of transdermal medication administration, stressing the skin's barrier role and drug permeation methods. Read More
-
-
-
Extreme and Severe Systemic Pain Caused by Rifampicin: A Case Report of a Rare Allergic Reaction
Authors: Tong-xin Li, Yan-mei Xiong, Wen-wan Gao, Bohao Jiang, Ying He, Shiyan He, Lei Xu and Song YangAvailable online: 10 February 2025More LessBackground Rifampicin is a first-line anti-tuberculosis drug, but it may cause severe allergic adverse reactions. Case Presentation This case report describes an unusual and severe adverse reaction to rifampicin in a 53-year-old male patient with pulmonary tuberculosis. The patient developed intense systemic pain within 4 hours of rifampicin administration, affecting multiple organs and joints, without typical allergic manifestati Read More
-
-
-
Comprehensive Review of Gestational Diabetes: Pathophysiology, Pharmacological Management and the Role of Pharmaceutical Care
Authors: Abdulkadir Abdu and Hossamaldeen BakreyAvailable online: 31 January 2025More LessThis review addresses the significant part pharmacological treatment plays in treating gestational diabetes mellitus (GDM), therefore enhancing the results for mother and child. Talking about the frequency and relevance of GDM would help to underline the need for good management. The pathophysiology presents a thorough examination of the fundamental processes, clarifying how hormonal changes seen during pregnan Read More
-
-
-
Rhabdomyolysis Following Trimethoprim-Sulfamethoxazole Therapy: A Case Report and Review of the Literature
Available online: 29 January 2025More LessBackground Trimethoprim-Sulfamethoxazole (TMP-SMX) is a commonly used antibiotic for the treatment of several infections, such as urinary tract infections, respiratory infections, and in certain cases, septic arthritis. Rhabdomyolysis (RM) is very rare and less than 20 cases have been reported, so far, in the literature, in particular in immunocompromised patients. Here, we report a case of TMP-SMX-induced RM in an immunoco Read More
-